Drug-labels.com

Ran-Fluoxetine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
10 mg, 20 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Ran-Fluoxetine

ABOUT THIS MEDICATION

What the medication is used for:

RAN-Fluoxetine Capsules BP has been prescribed by your doctor to relieve your symptoms of:

  • depression (feeling sad, a change in appetite or

    weight, difficulty concentrating or sleeping, feeling tired, headaches, unexplained aches and pain)

  • bulimia (eating disorder, characterized by self-

    induced vomiting after eating)

  • or obsessive-compulsive disorder (recurrent and

    intrusive thought, feeling, idea, or sensation; recurrent pattern of behaviour, or unwanted thoughts or actions)

What it does:

Fluoxetine belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs). Fluoxetine is thought to work by increasing the levels of a chemical in the brain called serotonin (5-hydroxytryptamine).

When it should not be used:

Do not use RAN-Fluoxetine Capsules BP if you:

  • are allergic to it or any of the components of its

    formulation (see What the nonmedicinal ingredients are:).

  • are currently or have recently taken the drug

    thioridazine.

  • are currently or have recently taken monamine

    oxidase anti-depressants (e.g. phenelzine sulphate, moclobemide).

What the medicinal ingredient is:

RAN-Fluoxetine Capsules BP contains the active ingredient fluoxetine hydrochloride.

What the nonmedicinal ingredients are:

RAN-Fluoxetine Capsules BP 10 mg and 20 mg contains colloidal anhydrous silica, magnesium stearate, pregelatinised starch and purified talc.

The capsule shells contain:

10 mg: black ink (black iron oxide, butyl alcohol,

dehydrated alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, strong ammonia solution), FD & C Blue no. 1, gelatin, iron oxide yellow and titanium dioxide.

20 mg: black ink (black iron oxide, butyl alcohol, dehydrated alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, strong ammonia solution), erythrosine, gelatin, indigo carmine, quinoline yellow and titanium dioxide.

What dosage forms it comes in:

RAN-Fluoxetine Capsules BP are available in 10 mg (green) and 20 mg (green and yellow) strength.

WARNINGS AND PRECAUTIONS

During treatment with these types of medications, it is important that you and your doctor have good ongoing communication about how you are feeling.

RAN-Fluoxetine Capsules BP are not for use in children under 18 years of age.

New or Worsened Emotional or Behavioural Problems

Particularly in the first few weeks or when doses are adjusted, a small number of patients taking drugs of this type may feel worse instead of better. They may experience new or worsened feelings of agitation, hostility, anxiety, impulsivity, or thoughts about suicide, self-harm or harm to others. Suicidal thoughts and actions can occur in any age group but may be more likely in patients 18 to 24 years old.

Should this happen to you or those in your care, consult your doctor immediately. Close observation by a doctor is necessary in this situation. Do not discontinue your medication on your own.

You may be more likely to think like this if you have previously had thoughts about harming yourself. You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Fluoxetine has an effect on the electrical activity of the heart

In very rare cases, this effect can lead to disturbances in heart rhythm. These heart rhythm disturbances are more likely in patients with risk factors, such as heart disease, or in the presence of certain drugs. In general, females and people more than 65 years in age are at higher risk. It is important to follow the instructions of your doctor with regard to dosing. If you experience any symptoms of a possible heart rhythm disturbance, such as dizziness, palpitations (sensation of rapid, pounding, or irregular heart beat), fainting, or seizures, you should seek immediate medical attention.

Before starting RAN-Fluoxetine Capsules BP, tell your doctor or pharmacists:

  • if you have ever had an allergic reaction to any

    medication

  • if you have QT/QTc prolongation or a family history

    of QT/QTc prolongation;

  • if you have a heart disease;
  • if you have a personal history of fainting spells;
  • if you have a family history of sudden cardiac death

    at <50 years;

  • if you have electrolyte disturbances (e.g., low blood

    potassium or magnesium levels) or conditions that could lead to electrolyte disturbances (e.g., vomiting, diarrhea, dehydration);

  • if you use diuretics, enemas and/or laxatives
  • all your medical conditions, including a history of

    liver or kidney problems, seizures or blackouts, diabetes, bleeding disorder or have been told that you have low platelets, glaucoma or increased pressure in the eyes, eye pain, or blurred vision.

  • if you had a recent bone fracture or were told you

    have osteoporosis or risk factors for osteoporosis.

  • any medications (prescription or nonprescription)

    you are taking or have recently taken, especially monoamine oxidase (MAO) inhibitors (e.g., phenelzine sulfate, tranylcypromine sulfate, moclobemide or selegeline) or thioridazine, or anticoagulants, acetylsalicylic acid (e.g., Aspirin) and other non-steroidal anti-inflammatory drugs (e.g., ibuprofen).

  • any natural or herbal products you are taking (e.g. St.

    John's Wort)

  • if you are pregnant or thinking about becoming

    pregnant, or if you are breast feeding

  • your habits of alcohol and /or street drug

    consumption

  • if you drive a vehicle or perform hazardous tasks

    during your work

Effects on Pregnancy and Newborns

If you are already taking RAN-Fluoxetine Capsules BP and have just found out that you are pregnant, you should talk to your doctor as soon as possible.

Taking RAN-Fluoxetine Capsules BP in early stages of pregnancy:

Some studies have suggested a small increased risk of birth defects affecting the heart in babies whose mothers took fluoxetine capsules during the first few months of pregnancy. In the general population, about 1 in 100 babies are born with a heart defect. The studies found that this increased to about 2 in 100 babies whose mothers took fluoxetine capsules during early pregnancy.

Taking RAN-Fluoxetine Capsules BP in later stages of pregnancy:

Possible complications at birth (from taking any newer antidepressant, including RAN-Fluoxetine Capsules BP):

Post-marketing reports indicate that some newborns whose mothers took an SSRI (selective serotonin reuptake inhibitor) or other newer anti-depressant during pregnancy have developed complications at birth requiring prolonged hospitalization, breathing support and tube feeding. Reported symptoms included feeding and/or breathing difficulties, seizures, tense or overly relaxed muscles, jitteriness and constant crying.

In most cases, the newer anti-depressant was taken during the third trimester of pregnancy. These symptoms are consistent with either a direct adverse effect of the anti-depressant on the baby, or possibly a discontinuation syndrome caused by sudden withdrawal from the drug. These symptoms normally resolve over time. However, if your baby experiences any of these symptoms, contact your doctor as soon as you can.

Persistent Pulmonary Hypertension (PPHN) and newer antidepressants:

The use of SSRIs, including RAN-Fluoxetine Capsules BP, during late pregnancy, may increase the risk of a serious lung condition called persistent pulmonary hypertension of the newborn (PPHN) that causes breathing difficulties in newborns soon after birth. In the general population, PPHN is known to occur in about 1 or 2 per 1000 newborns but this may be increased 2 to 6 times in babies whose mothers used SSRIs during late pregnancy.

If you are pregnant and taking an SSRI, or other newer anti-depressant, you should discuss the risks and benefits of the various treatment options with your doctor. It is very important that you do NOT stop taking these medications without first consulting your doctor. See SIDE EFFECTS AND WHAT TO DO ABOUT THEM section for more information.

Taking RAN-Fluoxetine Capsules BP may increase your risk of breaking a bone if you are elderly or have osteoporosis or have other major risk factors for breaking a bone. You should take extra care to avoid falls especially if you get dizzy or have low blood pressure.

INTERACTIONS WITH THIS MEDICATION

Serious Drug Interactions Do not use RAN-Fluoxetine Capsules BP if you are taking or have recently taken:

  • Monoamine oxidase inhibitor (e.g., phenelzine, tranylcypromine, moclobemide or selegiline, linezolid, methylene blue)
  • Thioridazine

You should tell your doctor if you are taking or have recently taken any medications (prescription, nonprescription or natural/herbal), especially:

  • other anti-depressants, such as SSRIs, certain tricylics, drugs used to treat schizophrenia, or bipolar depression (e.g. lithium)
  • anti-infectives
  • cancer drugs
  • asthma drugs
  • drugs to treat nausea and vomiting
  • painkillers
  • diuretics
  • certain medicines which may affect blood clotting

    and increase bleeding, such as oral anticoagulants (e.g., warfarin, dabigatran), acetylsalicylic acid (e.g. Aspirin) and other non-steroidal anti-inflammatory drugs (e.g. ibuprofen)

  • certain medicines used to treat patients with irregular

    heart beats (antiarrhythmics)

  • certain drugs used to treat diabetes
  • other drugs that affect serotonin, such as lithium,

    linezolid, drugs containing tryptophan, St. Johns Wort, triptans used to treat migraines

  • certain medicines used to treat pain, such as fentanyl

    (used in anaesthesia or to treat chronic pain), tramadol, tapentadol, meperidine, methadone, pentazocine

  • certain medicines used to treat cough, such as

    dextromethorphan

  • sedatives such as benzodiazapines

As with many drugs that work directly on the brain, use of alcohol while taking RAN-Fluoxetine Capsules BP should be limited/moderate.

PROPER USE OF THIS MEDICATION

Usual dose:

  • It is very important that you take RAN-Fluoxetine

    Capsules BP exactly as your doctor has instructed. Generally people take between 20 mg to 80 mg per day for depression and obsessive-compulsive disorder and between 20 and 60 mg per day for bulimia.

  • RAN-Fluoxetine Capsule BP is usually taken once a

    day. It may be taken with or without food. If you are taking capsules, you should swallow the capsules whole; do not chew them.

  • You should continue to take your medicine even if

    you do not feel better, as it may take a number of weeks for your medicine to work.

  • Keep taking your RAN-Fluoxetine Capsules BP until

    the doctor tells you to stop.

  • Talk to your doctor before you stop taking your

    medication on your own.

Remember:

This medicine has been prescribed only for you. Do not give it to anybody else, as they may experience undesirable effects, which may be serious.

Missed Dose

If you forget to take a dose of RAN-Fluoxetine Capsules BP, take it as soon as you remember. Take your next dose at the next scheduled time; do not try to make up for a missed dose by taking a double dose the next time.

Overdose:

In case of drug overdose, contact a health care
practitioner, hospital emergency department or regional
Poison Control Centre immediately, even if there are no
symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like other medications, RAN-Fluoxetine Capsules BP can cause some side effects. You may not experience any of them. For most patients, side effects are likely to be minor and temporary. However, some may be serious. Some of these side effects may be dose related. Consult your doctor if you experience these or other side effects, as the dose may have to be adjusted.

The most common side effects of fluoxetine capsules are:

  • nausea
  • dizziness
  • headache
  • anxiety
  • nervousness
  • drowsiness
  • insomnia (difficulty falling or staying asleep)
  • fatigue
  • weakness
  • diarrhea
  • upset stomach
  • dry mouth
  • loss of appetite
  • excessive sweating

Fluoxetine capsules do not usually affect people’s normal activities. However, some people feel sleepy while taking it, in which case they should not drive or operate machinery.

Although psychiatric disorders may be associated with decreases in sexual desire, performance and satisfaction, treatment with this medication may also affect sexual functioning. Occasionally, these symptoms may continue after stopping RAN-Fluoxetine Capsules BP.

RAN-Fluoxetine Capsules BP can raise your levels of a hormone called “prolactin” (measured with a blood test). Symptoms of high prolactin may include:

In men: breast swelling, difficulty in getting or maintaining erections, or other sexual dysfunction.

In women: breast discomfort, leakage of milk from the breasts, missed menstrual periods, or other problems with your cycle.

If you experience any symptoms of a possible heart rhythm disturbance, such as dizziness, palpitations, fainting or seizures, you should seek immediate medical attention.

Discontinuation Symptoms

Contact your doctor before stopping or reducing your dosage of RAN-Fluoxetine Capsules BP. Symptoms such as headache, insomnia, paresthesias (numbness, tingling, burning, or prickling sensation) nervousness, anxiety, nausea, sweating, dizziness, jitteriness and weakness and other symptoms have been reported after stopping fluoxetine capsules. These symptoms usually disappear without needing treatment. Tell your doctor immediately if you have these or any other symptoms. Your doctor may adjust the dosage of RAN-Fluoxetine Capsules BP to alleviate the symptoms. See WARNINGS AND PRECAUTIONS section for more information.

Effects on Newborns

Some newborns whose mothers took an SSRI (Selective Serotonin Uptake Inhibitor) or other newer antidepressants during pregnancy have shown such symptoms as breathing and feeding difficulties, jitteriness and constant crying. If your baby experiences any of these symptoms, contact your doctor as soon as you can. See WARNING AND PRECAUTIONS section for more information.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Seek immediate emergency medical assistance
Only if severeIn all cases
Common

Allergic

reactions [red skin, hives, itching,

swelling of the lips, face,

tongue, throat, trouble

breathing,

wheezing,

shortness of breath, skin rashes, blisters of the skin, sores or

pain in the

mouth

or eyes]

√
Allergic reactions (skin rash, hives alone)√
Unknown

Low Platelets: Bruising or

unusual bleeding from the skin or other areas

√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistSeek immediate emergency medical assistance
Only if severeIn all cases
UncommonHallucinations [strange visions or sounds]√
Inability to urinate√

Akathisia

[feeling restless and unable to sit or stand still]

√
Seizures [i.e. loss of consciousness with uncontrollable shaking (“fit”)]√

Mania

[overactive behaviour and thoughts]

√
Rare

Gastrointestinal bleeding

[vomiting blood or passing blood in stools]

√

Glaucoma:

Increased pressure in the eyes, eye pain and blurred vision

√
Liver disorder [symptoms include nausea, vomiting, loss of appetite combined with itching, yellowing of the skin or eyes, dark urine]√
Uncontrollable movements of the body or face√

Low sodium level in blood

[symptoms of tiredness, weakness, confusion combined with achy, stiff or uncoordinated muscles]

√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Seek immediate emergency medical assistance
Only if severeIn all cases
Very Rare

Serotonin

syndrome [a

combination of most or all of the following;

confusion,

restlessness,

sweating,

shaking,

shivering, high fever,

hallucinations, sudden jerking of the muscles, fast heartbeat]

√

See

Warnings &

Precautions

New or worsened emotional or

behavioural

problems

√

This is not a complete list of side effects. For any unexpected effects while taking RAN-Fluoxetine Capsules BP, contact your doctor or pharmacist

HOW TO STORE IT

Keep all medicines out of the reach and sight of children. RAN-Fluoxetine Capsules BP should be stored in its original package at 15-30ºC, in a dry place and out of direct sunlight. The expiry date of this medicine is printed on the package label. Do not use the medicine after the expiry date. If your doctor tells you to stop taking RAN-Fluoxetine Capsules BP or you find that they have passed their expiry date, please return any left over medicine to your pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at http://www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E Ottawa, ON K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at http://www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor Ranbaxy Pharmaceuticals Canada Inc. at: 1-866-840-1340

Date of preparation: April 24, 2013.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02405695

Revision date stated in the text: April 24, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ran-Fluoxetine

Rx or OTC
Prescription (Rx)?
DIN 02405695, 02405709
Schedule(s) PRESCRIPTION
Active ingredient(s) Fluoxetine (fluoxetine hydrochloride)
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AB Selective serotonin reuptake inhibitors
          1. N06AB03 Fluoxetine
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Cancelled Post Market
Current status date September 7, 2022
Strengths and forms
DIN Strength Dosage form(s) Current status
02405695 10 MG Capsule Cancelled Post Market September 7, 2022
02405709 20 MG Capsule Cancelled Post Market September 7, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.